Australian and U.S. researchers have shown that a small molecule inhibitor of RNA polymerase I blocked tumor growth in mouse models of lymphoma. Cylene Pharmaceuticals and the Peter MacCallum Cancer Centre plan to start a Phase I trial of the inhibitor in Australia this year.